Buy Breztri Aerosphere (budesonide/glycopyrrolate/formoterol fumarate) Online

0 out of 5

DISEASE INDICATIONS: Chronic Obstructive Pulmonary Disease MANUFACTURER: AstraZeneca Pharmaceuticals LP USAGE: Oral MEDICINE APPROVED BY: Food and Drug Administration (FDA) Pharmaceuticals and Medical Devices Agency (PMDA)   Breztri Aerosphere, including budesonide, glyrrolate and formoterol fumarate, is a drug that helps with the long-term maintenance of patients struggling with chronic obstructive pulmonary disease (COPD).

$313.50
Select optionsThis product has multiple variants. The options may be chosen on the product page
Add to wishlist

Buy Clenbuterol Harasawa Online

0 out of 5

DISEASE INDICATIONS: Amyotrophic Lateral Sclerosis (ALS) MANUFACTURER: Harasawa USAGE: Oral MEDICINE APPROVED BY: Pharmaceuticals and Medical Devices Agency (PMDA)   Clenbuterol is a drug utilized to treat individuals with bronchial asthma, chronic bronchitis, emphysema, acute bronchitis, or stress urinary incontinence. It is sometimes prescribed by physicians to treat patients with ALS for off-label use. Clenbuterol was formerly recognized by its brand name, TONIL (clenbuterol).

$105.60
Select optionsThis product has multiple variants. The options may be chosen on the product page
Add to wishlist

Buy Kalydeco (ivacaftor) Online

0 out of 5

DISEASE INDICATIONS: Cystic Fibrosis MANUFACTURER: Vertex Pharmaceuticals (Europe) Ltd USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Kalydeco (ivacaftor) is a medication that is approved for the treatment of cystic fibrosis (CF) in patients aged 4 months and above who possess at least one mutation in their CF gene that is receptive to Kalydeco.

From $7,434.90
Select optionsThis product has multiple variants. The options may be chosen on the product page
Add to wishlist

Buy Lucaftor (lumacaftor/ivacaftor) Online

0 out of 5

DISEASE INDICATIONS: Cystic Fibrosis MANUFACTURER: Gador SA USAGE: Oral MEDICINE APPROVED BY: ANMAT (ARG)   Lucaftor (lumacaftor/ivacaftor) is a medication prescribed to treat cystic fibrosis (CF) in patients aged 12 years or above who have two copies of the F508del mutation (F508del/F508del) in the CFTR gene.

$3,136.10
Select optionsThis product has multiple variants. The options may be chosen on the product page
Add to wishlist

Buy Orkambi (lumacaftor/ivacaftor) Online

0 out of 5

DISEASE INDICATIONS: Cystic Fibrosis MANUFACTURER: Vertex Pharmaceuticals (Europe) Ltd USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Therapeutic Goods Administration (TGA) Orkambi (lumacaftor/ivacaftor)* is a medication used to treat cystic fibrosis (CF) in patients with the F508del mutation in both copies of the CFTR gene.

From $11,094.60
Select optionsThis product has multiple variants. The options may be chosen on the product page
Add to wishlist

Buy Symdeko (tezacaftor / ivacaftor) Online

0 out of 5

DISEASE INDICATIONS: Cystic Fibrosis MANUFACTURER: Vertex Pharmaceuticals (Europe) Ltd USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Symdeko (tezacaftor/ivacaftor) is a medication intended for the treatment of cystic fibrosis (CF) patients who are 6 years and older. Available in tablet form, each tablet contains 100mg of tezacaftor and 150mg of ivacaftor and is recommended to be taken with another medicine containing ivacaftor alone, which has a strength of 150mg. The medication is marketed in the United States as Symdeko and in Europe as Symkevi.

$40,471.20
Select optionsThis product has multiple variants. The options may be chosen on the product page
Add to wishlist

Buy Symkevi (tezacaftor/ivacaftor) Online

0 out of 5

DISEASE INDICATIONS: Cystic Fibrosis MANUFACTURER: Vertex Pharmaceuticals (Europe) Ltd USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA)   Symkevi (tezacaftor/ivacaftor) is a tablet medicine approved for the treatment of cystic fibrosis (CF) patients who are 12 years or older. Each tablet contains 100mg of tezacaftor and 150mg of ivacaftor and must be taken in conjunction with another medicine that contains 150mg of ivacaftor alone. The medicine is sold under the brand name Symkevi in Europe and Symdeko in the United States.

$5,882.80
Select optionsThis product has multiple variants. The options may be chosen on the product page
Add to wishlist

Buy Tezspire (tezepelumab-ekko) Online

0 out of 5

DISEASE INDICATIONS: Asthma MANUFACTURER: Amgen / AstraZeneca AB USAGE: Subcutaneous MEDICINE APPROVED BY: Food and Drug Administration (FDA)   Tezspire (tezepelumab-ekko) is a medication prescribed as an add-on maintenance treatment for individuals aged 12 years and older, both adult and pediatric, with severe asthma.

$6,875.00
Select optionsThis product has multiple variants. The options may be chosen on the product page
Add to wishlist

Buy Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) Online

0 out of 5

  • DISEASE INDICATIONS: Chronic Obstructive Pulmonary Disease, Asthma
  • MANUFACTURER: GlaxoSmithKline
  • USAGE: Oral
  • MEDICINE APPROVED BY:
  • European Medical Agency (EMA)
  • Food and Drug Administration (FDA)
  • Pharmaceuticals and Medical Devices Agency (PMDA)
  Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) is prescribed as a continuous, maintenance therapy for individuals with asthma and chronic obstructive pulmonary disease (COPD).

$775.50
Select optionsThis product has multiple variants. The options may be chosen on the product page
Add to wishlist

Buy Trikafta (elexacaftor/tezacaftor/ivacaftor; ivacaftor) Online

0 out of 5

  • DISEASE INDICATIONS: Cystic Fibrosis
  • MANUFACTURER: Vertex Pharmaceuticals Incorporated
  • USAGE: Oral
  • MEDICINE APPROVED BY:
  • Food and Drug Administration (FDA)
  Trikafta (elexacaftor/tezacaftor/ivacaftor) is a medication used to treat cystic fibrosis in patients aged 12 years and older who have at least one F508del mutation in the CFTR gene.

From $40,150.00
Select optionsThis product has multiple variants. The options may be chosen on the product page
Add to wishlist

Buy Yupelri (revefenacin) Online

0 out of 5

  • DISEASE INDICATIONS: Chronic Obstructive Pulmonary Disease
  • MANUFACTURER: Theravance Biopharma
  • USAGE: Oral
  • MEDICINE APPROVED BY:
  • Food and Drug Administration (FDA)
Yupelri (revefenacin) is a medication approved by the Food and Drug Administration (FDA) for the treatment of patients with COPD.It is a bronchodilator, specifically classified as a long-acting muscarinic antagonist (LAMA), and it is primarily used in the management of chronic obstructive pulmonary disease (COPD). This medication is designed to help individuals with COPD breathe more easily by relaxing and opening up the airways in their lungs.

Read more
Add to wishlist